These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36048859)

  • 41. MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity.
    Yadava RS; Kim YK; Mandal M; Mahadevan K; Gladman JT; Yu Q; Mahadevan MS
    Hum Mol Genet; 2019 Jul; 28(14):2330-2338. PubMed ID: 30997488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Is Not Necessary for Prior Pharmacological Activation of AMPK to Increase Insulin Sensitivity of Mouse Skeletal Muscle.
    Jørgensen NO; Wojtaszewski JFP; Kjøbsted R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29662023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a novel phosphorylation site on TBC1D4 regulated by AMP-activated protein kinase in skeletal muscle.
    Treebak JT; Taylor EB; Witczak CA; An D; Toyoda T; Koh HJ; Xie J; Feener EP; Wojtaszewski JF; Hirshman MF; Goodyear LJ
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C377-85. PubMed ID: 19923418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.
    Holmes BF; Lang DB; Birnbaum MJ; Mu J; Dohm GL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E739-43. PubMed ID: 15165992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
    Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
    Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
    Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
    J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
    Christou M; Wengel J; Sokratous K; Kyriacou K; Nikolaou G; Phylactou LA; Mastroyiannopoulos NP
    Nucleic Acid Ther; 2020 Apr; 30(2):80-93. PubMed ID: 31873063
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of AMPK and PPARγ1 in exercise-induced lipoprotein lipase in skeletal muscle.
    Sasaki T; Nakata R; Inoue H; Shimizu M; Inoue J; Sato R
    Am J Physiol Endocrinol Metab; 2014 May; 306(9):E1085-92. PubMed ID: 24644240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.
    Crawford Parks TE; Marcellus KA; Péladeau C; Jasmin BJ; Ravel-Chapuis A
    Hum Mol Genet; 2020 Aug; 29(13):2185-2199. PubMed ID: 32504084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined pharmacological activation of AMPK and PPARδ potentiates the effects of exercise in trained mice.
    Manio MC; Inoue K; Fujitani M; Matsumura S; Fushiki T
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
    Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
    PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AICAR stimulation metabolome widely mimics electrical contraction in isolated rat epitrochlearis muscle.
    Miyamoto L; Egawa T; Oshima R; Kurogi E; Tomida Y; Tsuchiya K; Hayashi T
    Am J Physiol Cell Physiol; 2013 Dec; 305(12):C1214-22. PubMed ID: 24088893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
    Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
    Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reductions in RIP140 are not required for exercise- and AICAR-mediated increases in skeletal muscle mitochondrial content.
    Frier BC; Hancock CR; Little JP; Fillmore N; Bliss TA; Thomson DM; Wan Z; Wright DC
    J Appl Physiol (1985); 2011 Sep; 111(3):688-95. PubMed ID: 21700896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice.
    Maarbjerg SJ; Jørgensen SB; Rose AJ; Jeppesen J; Jensen TE; Treebak JT; Birk JB; Schjerling P; Wojtaszewski JF; Richter EA
    Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E924-34. PubMed ID: 19654283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
    Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes.
    Mikhail AI; Nagy PL; Manta K; Rouse N; Manta A; Ng SY; Nagy MF; Smith P; Lu JQ; Nederveen JP; Ljubicic V; Tarnopolsky MA
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35316212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Splicing biomarkers of disease severity in myotonic dystrophy.
    Nakamori M; Sobczak K; Puwanant A; Welle S; Eichinger K; Pandya S; Dekdebrun J; Heatwole CR; McDermott MP; Chen T; Cline M; Tawil R; Osborne RJ; Wheeler TM; Swanson MS; Moxley RT; Thornton CA
    Ann Neurol; 2013 Dec; 74(6):862-72. PubMed ID: 23929620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.